Text Size

Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)

This study has been completed.
Sponsor:
Collaborator:
Alberta Cancer Foundation
Information provided by:
Alberta Health Services
ClinicalTrials.gov Identifier:
NCT00156871
First received: September 8, 2005
Last updated: January 18, 2012
Last verified: August 2011
History of Changes
  Purpose

The purpose of this study is to investigate the impact of fatigue in severely affected transplant patients.


Condition Intervention
Fatigue
 Behavioral: exercise

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Alberta Health Services:

Primary Outcome Measures:
  • Fatigue score

Estimated Enrollment: 24
Study Start Date: April 2003
Study Completion Date: December 2005
Detailed Description:

Investigates impact of a monitored program in kinesiology lab at the University of Calgary on fatigue in severely affected transplant patients.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Severe fatigue post transplant

Exclusion Criteria:

  • Other conditions contributing to fatigue (graft versus host disease)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00156871

Locations
Canada, Alberta
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2
Sponsors and Collaborators
Alberta Health Services
Alberta Cancer Foundation
Investigators
Study Director: James Russell Alberta Health Services
Principal Investigator: Nicole Colos-Reed, Phd University of Calgary
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00156871     History of Changes
Other Study ID Numbers: 181710-DRD 16, ACF 717905155
Study First Received: September 8, 2005
Last Updated: January 18, 2012
Health Authority: Canada: Health Canada

Keywords provided by Alberta Health Services:
transplant
fatigue
exercise
Malignant disease

Additional relevant MeSH terms:
Fatigue
Signs and Symptoms

ClinicalTrials.gov processed this record on June 18, 2013